Pfizer Norvasc Patent: Will Court Limit Extension To “Approved” Product?

Dr. Reddy's reliance on Norvasc data in its 505(b)(2) application for amlodipine maleate could impact an appeals court's determination of whether Pfizer's patent term extension applies only to the approved besylate salt form of the drug